FDA Investigator Dr. Koffi A Amegadje
Dr. Koffi A Amegadje has inspections in 4 countries as of 16 Feb 2024. Dr. Koffi A Amegadje has collaborated with a combined 358 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
35
Last Inspection Date:
16 Feb 2024
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
India,
Taiwan,
China
Co-Investigator(s):
Ann B Borromeo,
Anna E Fain,
Barbara D Wright,
Brandy D Brown,
Courtney N Long,
Cynthia A Harris, MD, RN,
Dana M Klimavicz,
Donna D Gallien, MPH,
Emily A Baldwin,
Emily A Green,
Emily E Smith,
Ernest H Blackwood,
Juanelma H Palmer,
Kenneth R Merritt,
Laura L Staples,
Lucilla Facchin,
Nicole M Bell,
Patricia S Smith,
Sereen Gmorgan Murray,
Vanessa E Coulter
Dr. Koffi A Amegadje's Documents
Publish Date | Document Type | Title |
---|---|---|
February, 2022 | FDA 483 | Robert Joseph Jeanfreau, MD - Form 483, 2022-02-25 |
August, 2023 | FDA 483 | R. Doyle Stulting, MD - Form 483, 2023-08-18 |
March, 2021 | EIR | John P Devincenzo MD - EIR, 2021-03-16 |
July, 2023 | FDA 483 | Louisiana State University Health Sciences Center - Form 483, 2023-07-26 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more